Reuters logo
BRIEF-Glaxo ADRs up 2 pct after FDA advisory panel votes
April 17, 2013 / 6:31 PM / in 5 years

BRIEF-Glaxo ADRs up 2 pct after FDA advisory panel votes

NEW YORK, April 17 (Reuters) - Glaxosmithkline Plc: * U.S.-traded shares up 2 percent after FDA advisory panel votes

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below